Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
NCT00352482Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in idiopathic pulmonary fibrosis (IPF), pulmonary hypertension (PH), sponsored by National Heart, Lung, and Blood Institute. Started Nov 2004; status: completed.
02
Drugs
sildenafil
03
Conditions
idiopathic pulmonary fibrosis (IPF)pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00352482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352482.